Nature communications

Balance between bile acid processing and breakdown may change gut inflammation outcomes

Updated

Abstract

BaatKO mice with severe colitis symptoms were partially rescued by taurocholate (TCA) supplementation.

  • Host-conjugated are produced by the liver and microbiome and play a role in gastrointestinal health.
  • Supplementation with TCA improved epithelial barrier integrity and goblet cell function in a colitis mouse model.
  • Metabolomics revealed that TCA was extensively metabolized to secondary bile acids after supplementation.
  • The hydrolytic capacity of diverse gut bacteria on conjugated bile acids varied based on the bacterium and amino acid conjugate.
  • Certain gene sequences were found to be enriched in human Crohn's disease patients, notably from Ruminococcus gnavus.
  • Both host and microbially conjugated bile acids may influence inflammatory bowel disease, depending on the balance of conjugation and deconjugation.

Simplified

Key numbers

0.05
Increase in MUC-2 Expression
MUC-2 gene expression in TCA-treated DSS mice vs. DSS control group.
14.68%
Abundance Reduction
Proportion of BSHs with increased relative abundance in CD patients vs. healthy controls.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free